ClinicalTrials.govpublic full text
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
type 2 diabetes, csii, exenatide, double blind placebo controlled study, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 880732
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.